FDA Warning Letter: Bioptimal International
type: Action
additional type: https://schema.org/RegulationAction
start time: 2024-05-07
description: CGMP/QSR/Medical Devices/Adulterated. Issued by FDA "OHT2: Office of Cardiovascular Devices, Office of Product Evaluation and Quality" on 2024-04-03.
agent: FDA "OHT2: Office of Cardiovascular Devices, Office of Product Evaluation and Quality"
object: Bioptimal International
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
source organization: U.S. Food and Drug Administration
publisher: AI Analytics

PropertyValue
property ID: FDA Warning Letter ID
value: 87937e7b6a2d33fe

AI Analytics
type: Organization